![2020 04 14 17 44 0981 Hyundai Drive Thumb](https://img.labpulse.com/files/base/smg/all/image/2020/04/lp.2020_04_14_17_44_0981_Hyundai_drive_thumb.png?auto=format%2Ccompress&q=70&w=400)
Hyundai Motor America has provided $4 million in grants to 22 U.S. hospitals to expand support for COVID-19 drive-through testing.
The money comes from the Hyundai Hope On Wheels program, a 501(c)(3) nonprofit organization committed to finding a cure for childhood cancer.
![COVID-19 Drive-Thru Testing Center at Children's National Hospital in Washington, DC. Image courtesy of Hyundai.](https://img.labpulse.com/files/base/smg/all/image/2020/04/lp.2020_04_14_17_59_1131_Hyundai_drive_20200414180044.png?auto=format%2Ccompress&fit=max&q=70&w=400)
In addition, the company has initiated an in-kind donation of 65,000 COVID-19 reverse transcription polymerase chain reaction (RT-PCR) tests developed by South Korean firm Seegene. The test is designed to simultaneously detect three different SARS-CoV-2 genes (N, E, and RdRP). The tests will be distributed to hospitals in the U.S., with a focus on cities that have been particularly hard hit by the novel coronavirus, such as New Orleans, Chicago, and Detroit.